Gonad differentiation in male zebrafish involves a transformation from a ‘juvenile ovary’ to testis. In our study, this phenomenon was analysed using a stable transgenic line (vas::egfp) created by Krovel & Olsen (Mechanisms of Development, 116: 141–150, 2002). Our data obtained by histological and immunohistochemical methods show that the onset of enhanced green fluorescent protein (EGFP) expression marks the conversion of the bipotential gonad into a ‘juvenile ovary’, and its subsequent decrease in the males indicates transformation into a testis. Furthermore, during the ‘juvenile ovary’ stage, a high level of variation was observed among individuals not only in the starting point and duration of EGFP expression but also in its intensity. The intensity of reporter expression in the males ranged from a high level of expression – similar to that observed in females – to invisible expression and correlated with the number of oocytes, the shape of ‘juvenile ovary’ and its lumen. Therefore, the authors conclude that although all males develop ‘juvenile ovaries’, they differ vastly in the extent of their commitment toward femaleness during this stage before testis differentiation. The differentiating zebrafish testis shows morphological features similar to those of the transforming gonad of protogynous hermaphrodites, and therefore, it could be a good model for the study of the process of female‐to‐male sex change in adult teleosts.

-PURPOSE: Triple negative breast cancers (estrogen, progesterone and human epidermal growth factor 2 (HER2) receptor-negative) are among the most aggressive forms of cancers with limited treatment options. Doxorubicin is one of the agents found in many of the current cancer treatment protocols, although its use is limited by dose-dependent cardiotoxicity. This work investigates one of the ways to suppress cancer growth by inhibiting tumor cell ability to remove acid accumulated during its metabolism by proton pump inhibitor esomeprazole (a drug with extensive clinical use) which could serve as an addition to doxorubicin therapy. METHODS: In this work, we have investigated growth suppression of triple-negative breast cancer cells MDA-MB-468 by esomeprazole and doxorubicin by trypan blue exclusion assay.

Localized Ca2+ signals were consistently visualized in the formed somites of intact zebrafish embryos during the early segmentation period. Unlike the regular process of somitogenesis, these signals were stochastic in nature with respect to time and location. They did, however, occur predominantly at the medial and lateral boundaries within the formed somites. Embryos were treated with modulators of [Ca 2+ ] i to explore the signal generation mechanism and possible developmental function of the stochastic transients. Blocking elements in the phosphoinositol pathway eliminated the stochastic signals but had no obvious effect, stochastic or otherwise, on the formed somites. Such treatments did, however, result in the subsequently formed somites being longer in the mediolateral dimension. Targeted uncaging of buffer (diazo-2) or Ca 2+ (NP-ethyleneglycoltetraacetic acid [EGTA]) in the presomitic mesoderm, resulted in a regular mediolateral lengthening and shortening, respectively, of subsequently formed somites. These data suggest a requirement for IP 3 receptor-mediated Ca 2+ release during convergence cell movements in the presomitic mesoderm, which appears to have a distinct function from that of the IP 3 receptor-mediated stochastic Ca 2+ signaling in the formed somites.